AP20187
Detailed Description
AP20187AP20187 is a synthetic, cell-permeable ligand that can be used to induce homodimerization of fusion proteins containing the DmrB domain.
Target: small dimerizer drug
Systemic AP20187 administration results in time-dependent LFv2IRE tyrosine phosphorylation and activation of the insulin signaling pathway in both liver and muscle of AAV-treated NOD mice.
Target:PKC
Product Links:http://www.medchemexpress.cn/ap20187.html
Permanent link:http://www.medchemexpress.com/ap20187.html